Table 2.
Study outcomes
|
|
Total (n = 36)
|
CYA (n = 19)
|
Coils + CYA (n = 17)
|
P
value
|
| Early rebleeding (n of events), n (%) | 3/36 (8.3) | 3/19 (15.8) | 0 | 0.2311 |
| Adverse events (n of events), n (%) | 5/36 (13.8) | 3/19 (15.8) | 2/17 (11.8) | 1.0001 |
| Treatment modality, n (%) | 0.0012 | |||
| Ambulatory | 23 (63.1) | 7 (36.8) | 16 (94.1) | |
| Hospitalization | 13 (36.1) | 12 (63.2) | 1 (5.9) | |
| No of endoscopic procedures, total | 45 | 28 | 17 | N/A |
| No. of endoscopic procedures per patient, median (range) | 1 (1-4) | 1 (1-4) | 1 | 0.0143 |
| Length of hospitalization (d), range | 0–14 | 0-14 | 0–1 | < 0.0014 |
| Intensive care unit | 0-11 | 0-11 | - | 0.0124 |
| Intermediate care unit | 0-14 | 0-14 | - | 0.0014 |
| Emergency Department | 0–1 | - | 0–1 | 0.3034 |
| Cost per procedure (USD) | N/A | 816.70 | 2247.00 | N/A |
| Cost per procedure (USD), mean (range) | 1696.29 (816.70-3266.80) | 1203.56 (816.70-3266.80) | 2247.00 | < 0.0015 |
| Coil cost (1 coil = $ 300, USD), mean (range) | 291.67 (0-900.00) | 0 | 617.65 (300.00-900.00) | < 0.0015 |
| CYA cost (1 vial × 0.3 mL = $ 20.5, USD), mean (range) | 130.97.00 (41.00-451.00) | 146.74 (41.00-451.00) | 113.35 (82.00-164.00) | 0.1415 |
| Total procedure cost (USD), mean (range) | 2118.93 (857.70-3717.80) | 1350.29 (857.70-3717.80) | 2978.00 (2629.00-3270.00) | < 0.0015 |
| Hospitalization cost (USD), mean (range) | 5158.31 (0-45857.20) | 9710.60 (0-45857.20) | 70.46 (0-1197.80) | 0.0105 |
| Total treatment cost (procedure + hospitalization, USD) mean (range) | 7277.20 (919.20-49575.00) | 11060.89 (919.20-49575.00) | 3007.13 (2629.00-3867.80) | 0.0305 |
1
Fisher's Exact Test for Count Data.
2
Pearson's Chi-squared test with Yates' continuity correction.
3
Mann–Whitney U test.
4
Gray’s test.
5
Welch Two Sample t-test. CYA: Cyanoacrylate; SD: Standard deviation; GV: Gastric varix; GOV: Gastroesophageal varices; IGV: Isolated gastric varices, USD: United States dollar; N/A: Not available.